Columns

CF treatments are miraculous, but what about rare mutations?

For many years, I’ve had to endure the ongoing praise for life-changing cystic fibrosis (CF) medications. Let me explain. CFTR modulators like the most recently approved drug Trikafta (elexacaftor/tezacaftor/ivacaftor) have completely changed the way that many patients address the chronic challenges of CF. I’ve watched…

When praising CF medications, Orkambi deserves a mention

Note: This column describes the author’s own experiences with Orkambi, Trikafta, and Symdeko. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. In December 2019, I was working through my final year of a master’s degree in creative writing. Most…